Jif Peanut Butter Recall Issued Over Salmonella Food Poisoning Risks
Following more than a dozen cases of salmonella food poisoning, Jif peanut butter products have been recalled in the United States and Canada.
The Jif peanut butter recall was announced by the FDA on May 20, impacting various types of peanut butter in a range of package sizes, which may have become contaminated with salmonella at a Smucker manufacturing facility in Lexington, Kentucky.
At least 14 people from a dozen different states have reportedly become sick from Jif peanut butter, with at least two severe illnesses resulting in hospitalization.
Do You Have a Case? JIF PEANUT BUTTER RECALL LAWSUIT
Were you or a loved one hospitalized due to salmonella poisoning from Jif peanut butter?CONTACT A LAWYER
The recalled peanut butter was distributed in retail stores and other outlets, including lot codes 1274425 – 2140425 printed alongside the best-if-used-by date on the side of the package.
Recalled peanut butter products include various size jars of Jif creamy, Crunchy, Natural Crunchy, Natural Honey, and varieties of peanut butter in plastic jars, squeeze pouches, and “to go” packaging. A full list of recalled products is available in the recall notice linked above.
Salmonella can cause serious and sometimes fatal infections in young children and elderly people, or those with weakened immune systems. Symptoms of Salmonella infection include fever, diarrhea, nausea, vomiting, and abdominal pain.
In some cases, the bacteria can travel into the bloodstream and lead to more severe illness such as aneurysm, endocarditis, and arthritis. Generally healthy people recover from Salmonella infection in about seven to 10 days.
Consumers who have Jif products affected by the recall in their possession should throw away the products immediately. Questions about the recall and side effects can be directed to Jif at 800-828-9980 or www.jif.com/contact-us.
"*" indicates required fields
More Top Stories
The President has signed the Camp Lejeune Justice Act into law as part of a larger package of veterans toxic chemical exposure health care benefits, which will allow those exposed to water contamination while living or serving on the base to file lawsuits against the federal government.
Ahead of the first Zantac lawsuit trials, slated to begin next year, investors sold off Sanofi, GlaxoSmithKline and Pfizer stocks, anticipating massive court losses and costs.
A federal judge has issued a pretrial scheduling order setting the first Nexium kidney damage lawsuit to go before a jury in November.